PHIO Q4 2021 Earnings — Phio Pharmaceuticals Corp. Revenue & Financial Results | Market Cap Arena

PHIOPhio Pharmaceuticals Corp.

$13M

Q4 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$2M

Operating Income

-$3M

Net Income

-$3M

EPS (Diluted)

$-27.57

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$138,000

Balance Sheet

Total Assets

$25M

Total Liabilities

$3M

Stockholders' Equity

$22M

Cash & Equivalents

$24M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$2M	-$45,000	-4844.4%
Operating Income	-$3M	-$2M	-40.1%
Net Income	-$3M	-$2M	-40.2%